Panagora Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.53M Sell
394,034
-135,536
-26% -$1.21M 0.02% 372
2025
Q1
$3.97M Sell
529,570
-306,402
-37% -$2.3M 0.02% 372
2024
Q4
$6.29M Buy
835,972
+159,680
+24% +$1.2M 0.03% 306
2024
Q3
$5.14M Buy
676,292
+25,974
+4% +$197K 0.02% 345
2024
Q2
$4.02M Buy
650,318
+17,759
+3% +$110K 0.02% 360
2024
Q1
$3.21M Sell
632,559
-36,508
-5% -$185K 0.02% 436
2023
Q4
$4.01M Sell
669,067
-58,413
-8% -$350K 0.02% 362
2023
Q3
$5.15M Buy
727,480
+41,971
+6% +$297K 0.03% 289
2023
Q2
$4.83M Sell
685,509
-6,374
-0.9% -$44.9K 0.03% 338
2023
Q1
$5.77M Sell
691,883
-3,718
-0.5% -$31K 0.04% 342
2022
Q4
$7.99M Buy
695,601
+193,020
+38% +$2.22M 0.05% 293
2022
Q3
$6.33M Buy
502,581
+116,879
+30% +$1.47M 0.04% 312
2022
Q2
$4.08M Sell
385,702
-6,306
-2% -$66.7K 0.03% 436
2022
Q1
$6.37M Buy
392,008
+64,476
+20% +$1.05M 0.03% 359
2021
Q4
$4.54M Buy
327,532
+104,126
+47% +$1.44M 0.02% 424
2021
Q3
$3.21M Buy
223,406
+220,496
+7,577% +$3.17M 0.02% 542
2021
Q2
$46K Buy
2,910
+2,425
+500% +$38.3K ﹤0.01% 2078
2021
Q1
$5K Buy
485
+150
+45% +$1.55K ﹤0.01% 2567
2020
Q4
$2K Buy
+335
New +$2K ﹤0.01% 2605
2017
Q2
Sell
-27,165
Closed -$228K 2595
2017
Q1
$228K Sell
27,165
-4,312
-14% -$36.2K ﹤0.01% 1612
2016
Q4
$199K Hold
31,477
﹤0.01% 1752
2016
Q3
$139K Buy
31,477
+4,312
+16% +$19K ﹤0.01% 1880
2016
Q2
$77K Buy
+27,165
New +$77K ﹤0.01% 1975
2016
Q1
Sell
-8,393
Closed -$87K 2295
2015
Q4
$87K Buy
8,393
+4,398
+110% +$45.6K ﹤0.01% 1831
2015
Q3
$46K Sell
3,995
-1,713
-30% -$19.7K ﹤0.01% 2008
2015
Q2
$85K Buy
+5,708
New +$85K ﹤0.01% 1999
2014
Q2
Sell
-246,190
Closed -$2.61M 2326
2014
Q1
$2.61M Buy
+246,190
New +$2.61M 0.01% 764